Lataa...
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
BACKGROUND: Diabetes is a leading cause of mortality and morbidity across the world. Over 50% of deaths among diabetic patients are caused by cardiovascular diseases. Cardiac diastolic dysfunction is one of the key early signs of diabetic cardiomyopathy, which often occurs before systolic dysfunctio...
Tallennettuna:
| Julkaisussa: | Cardiovasc Diabetol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6122727/ https://ncbi.nlm.nih.gov/pubmed/30180843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0767-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|